Medindia

X

Probactive Biotech, Inc. Announces an Agreement to Co-Develop Novel Biopharmaceuticals for Cancer with Dalat Nuclear Research Institute of Vietnam

Tuesday, June 22, 2010 Corporate News J E 4
Advertisement

Contact:

Henry Smith, Ph.D.

Probactive Biotech, Inc.

11555 Monarch Street

Garden Grove, CA 92841

Phone: (714) 903-1000

Fax: (714) 903-1010

Info@Probactive.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Access Pharma Sponsors Oral Mucositis Symposium To...
S
Neurologix Announces Successful Phase 2 Trial of G...